Genomic Health (GHDX) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q3 EPS of $0.06, $0.08 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $83.8 million versus the consensus estimate of $87 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
